Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2024 02:35 ET | Source: INVENTIVA

Inventiva announces Filing of 2024 Half-Year Report – Conditions for Accessing or Consulting the Report

Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company...
October 14, 2024 02:30 ET | Source: INVENTIVA

Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study

Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of specified conditions, from both new and existing investors, and up to $30 million...
October 09, 2024 14:23 ET | Source: Peapack-Gladstone Financial Corporation

Peapack-Gladstone Bank Hires Michael Anthony Guarino, Esq., CRCM as Senior Vice President

BEDMINSTER, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack-Gladstone Bank are proud to announce that Michael Anthony...
September 25, 2024 16:00 ET | Source: INVENTIVA

Inventiva provides a corporate update and reports its unaudited 2024 first-half financial results

Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical powering of the study expected to be superior to 95% for...
September 13, 2024 19:21 ET | Source: Edward Jones Canada

Edward Jones expands presence in Atlantic Canada with first woman-led branch in Fredericton, New Brunswick

FREDERICTON, New Brunswick, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Edward Jones Canada is proud to announce the grand opening of its first branch office in Fredericton, New Brunswick. This milestone event...
September 08, 2024 20:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
August 30, 2024 00:30 ET | Source: HUTCHMED (China) Limited

HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has voluntarily withdrawn...
August 21, 2024 09:00 ET | Source: ApplyBoard

ApplyBoard Announces 2024 International Alumni of Impact Winners

KITCHENER, Ontario, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ApplyBoard, the leading international student mobility platform, today announced the winners of its 2024 International Alumni of Impact program....
August 20, 2024 08:05 ET | Source: Brunswick Corporation

Brunswick Corporation Announces Organizational Changes

METTAWA, Ill., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Brunswick Corporation, (NYSE: BC), the world’s leading marine technology company, is announcing the following changes to its organization that are...
August 08, 2024 08:30 ET | Source: Adlai Nortye Ltd.

Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage biotechnology...